Liu Y, Sun L, Guo H, Zhou S, et al. Targeting SLP2-mediated lipid metabolism reprograming restricts proliferation and metastasis of hepatocellular carcinoma and promotes sensitivity to Lenvatinib. Oncogene 2022 Dec 6. doi: 10.1038/s41388-022-02551.
PMID: 36473908